Reviewed,
UniProtKB/Swiss-Prot Q60591 (NFAC2_MOUSE)
Last modified
February 9, 2010.
Version 101.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Nuclear factor of activated T-cells, cytoplasmic 2 Alternative name(s): T-cell transcription factor NFAT1 NFAT pre-existing subunit Short name=NF-ATp | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 927 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF. |
| Subunit structure | Member of the multicomponent NFATC transcription complex that consists of at least two components, a pre-existing cytoplasmic component NFATC2 and an inducible nuclear component NFATC1. Other members such as NFATC4, NFATC3 or members of the activating protein-1 family, MAF, GATA4 and Cbp/p300 can also bind the complex. The phosphorylated form specifically interacts with XPO1; which mediates nuclear export. NFATC proteins bind to DNA as monomers. Interacts with NFATC2IP. Ref.6 Ref.9 |
| Subcellular location | Cytoplasm. Nucleus. Note: Cytoplasmic for the phosphorylated form and nuclear after activation that is controlled by calcineurin-mediated dephosphorylation. Rapid nuclear exit of NFATC is thought to be one mechanism by which cells distinguish between sustained and transient calcium signals. The subcellular localization of NFATC plays a key role in the regulation of gene transcription. Ref.9 |
| Tissue specificity | Expressed in thymus, spleen, heart, testis, brain, placenta, muscle and pancreas. |
| Domain | Rel Similarity Domain (RSD) allows DNA-binding and cooperative interactions with AP1 factors By similarity. |
| Post-translational modification | In resting cells, phosphorylated by NFATC-kinase on at least 18 sites in the 99-365 region. Upon cell stimulation, all these sites except Ser-245 are dephosphorylated by calcineurin. Dephosphorylation induces a conformational change that simultaneously exposes an NLS and masks an NES, which results in nuclear localization. Simultaneously, one site among Ser-53; Ser-54 and Ser-56 is phosphorylated; which is required for full transcriptional activity. Ref.9 Ref.10 |
| Sequence similarities | Contains 1 RHD (Rel-like) domain. |
| Sequence caution | The sequence AAC52929.1 differs from that shown. Reason: Miscellaneous discrepancy. Chimeric cDNA fused with Phyhd1 (Lrrc8a). |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transcription Transcription regulation |
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing |
| Domain | Repeat |
| Ligand | DNA-binding |
| Molecular function | Activator |
| PTM | Phosphoprotein |
| Technical term | Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | cytokine production Inferred from direct assay. Source: MGI positive regulation of transcription from RNA polymerase II promoter Ref.3Inferred from direct assay. Source: MGI transcriptionInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | cytosol Inferred from direct assay. Source: MGI nucleusInferred from direct assay. Source: MGI |
| Molecular function | sequence-specific DNA binding Inferred from direct assay. Source: MGI transcription activator activity Ref.3Inferred from direct assay. Source: MGI transcription factor activityInferred from direct assay. Source: MGI |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform C (identifier: Q60591-3) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform B (identifier: Q60591-2) The sequence of this isoform differs from the canonical sequence as follows: 910-927: VNEIIRKEFSGPPSRNQT → ELIDTHLSWIQNIL | ||||||
| Isoform D (identifier: Q60591-4) The sequence of this isoform differs from the canonical sequence as follows: 619-806: DGQQIWEMEA...QGSTLRHTSS → GPAGTCETRP...PGSSLVLLAL | ||||||
| Isoform A (identifier: Q60591-1) The sequence of this isoform is not available. | ||||||
| Note: Ref.2 (AAC52929) sequence is a chimeric cDNA. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 927 | 927 | Nuclear factor of activated T-cells, cytoplasmic 2 | PRO_0000205179 | |||||
Regions | |||||||||
| Repeat | 186 – 202 | 17 | 1 | ||||||
| Repeat | 215 – 231 | 17 | 2 | ||||||
| Repeat | 274 – 290 | 17 | 3; approximate | ||||||
| Domain | 394 – 576 | 183 | RHD | ||||||
| DNA binding | 423 – 430 | 8 | |||||||
| Region | 111 – 116 | 6 | Calcineurin-binding | ||||||
| Region | 119 – 201 | 83 | Trans-activation domain A (TAD-A) | ||||||
| Region | 163 – 177 | 15 | Required for cytoplasmic retention of the phosphorylated form | ||||||
| Region | 186 – 292 | 107 | 3 X approximate SP repeats | ||||||
| Motif | 253 – 255 | 3 | Nuclear localization signal | ||||||
Amino acid modifications | |||||||||
| Modified residue | 53 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 54 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 56 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 99 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 110 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 136 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 170 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 173 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 174 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 176 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 177 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 179 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 182 | 1 | Phosphoserine Probable | ||||||
| Modified residue | 215 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 219 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 223 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 238 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 245 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 270 | 1 | Phosphoserine Ref.9 Ref.10 | ||||||
| Modified residue | 276 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 278 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 282 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 328 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 365 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 601 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 757 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 761 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 860 | 1 | Phosphoserine By similarity | ||||||
Natural variations | |||||||||
| Alternative sequence | 619 – 806 | 188 | DGQQI…RHTSS → GPAGTCETRPLPISLISADR LSPWLSRLQRNPPGSVFRCS VLLPAPGSSLVLLAL in isoform D. | VSP_005597 | |||||
| Alternative sequence | 910 – 927 | 18 | VNEII…SRNQT → ELIDTHLSWIQNIL in isoform B. | VSP_005596 | |||||
Experimental info | |||||||||
| Mutagenesis | 112 | 1 | R → A: Lowers dephosphorylation. Ref.7 | ||||||
| Mutagenesis | 114 | 1 | E → A: Lowers dephosphorylation. Ref.7 | ||||||
| Mutagenesis | 116 | 1 | T → A: No dephosphorylation. Ref.7 | ||||||
| Mutagenesis | 164 | 1 | R → A: Induces aberrant nuclear localization of the phosphorylated form. Ref.9 | ||||||
| Mutagenesis | 423 | 1 | R → A: Decrease in binding to DNA. Ref.5 | ||||||
| Mutagenesis | 425 | 1 | H → A: No change in binding to DNA. Ref.5 | ||||||
| Mutagenesis | 426 | 1 | Y → A: Decrease in binding to DNA. Ref.5 | ||||||
| Mutagenesis | 428 | 1 | T → A: No change in binding to DNA. Ref.5 | ||||||
| Mutagenesis | 428 | 1 | T → C: No change in binding to DNA and confers DNA-binding sensitivity to sulfhydryl modifications. Ref.5 | ||||||
| Mutagenesis | 429 | 1 | E → A: Decrease in binding to DNA. Ref.5 | ||||||
| Sequence conflict | 78 | 1 | L → P in AAK49895. Ref.3 | ||||||
| Sequence conflict | 287 | 1 | L → P in AAC52929. Ref.2 | ||||||
| Sequence conflict | 287 | 1 | L → P in AAC52930. Ref.2 | ||||||
| Sequence conflict | 287 | 1 | L → P in AAC52931. Ref.2 | ||||||
| Sequence conflict | 802 | 1 | R → P in CAM15671. Ref.4 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Isolation of the cyclosporin-sensitive T cell transcription factor NFATp." McCaffrey P.G., Luo C., Kerpolla T.K., Jain J., Badalian T.M., Ho A.M., Burgeon E., Lane W.S., Lambert J.N., Curran T., Verdine G.L., Rao A., Hogan P.G. Science 262:750-754(1993) [PubMed: 8235597] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE (ISOFORM A). |
| [2] | "Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes." Luo C., Burgeon E., Carew J.A., McCaffrey P.G., Badalian T.M., Lane W.S., Hogan P.G., Rao A. Mol. Cell. Biol. 16:3955-3966(1996) [PubMed: 8668213] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C). |
| [3] | "Identification and characterization of a novel nuclear factor of activated T-cells-1 isoform expressed in mouse brain." Plyte S., Boncristiano M., Fattori E., Galvagni F., Paccani S.R., Majolini M.B., Oliviero S., Ciliberto G., Telford J.L., Baldari C.T. J. Biol. Chem. 276:14350-14358(2001) [PubMed: 11278367] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM D). Strain: C57BL/6. Tissue: Brain. |
| [4] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed: 19468303] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [5] | "A similar DNA-binding motif in NFAT family proteins and the Rel homology region." Jain J., Burgeon E., Badalian T.M., Hogan P.G., Rao A. J. Biol. Chem. 270:4138-4145(1995) [PubMed: 7876165] [Abstract] Cited for: MUTAGENESIS OF ARG-423; HIS-425; TYR-426; THR-428 AND GLU-429. |
| [6] | "NF-AT-driven interleukin-4 transcription potentiated by NIP45." Hodge M.R., Chun H.J., Rengarajan J., Alt A., Lieberson R., Glimcher L.H. Science 274:1903-1905(1996) [PubMed: 8943202] [Abstract] Cited for: INTERACTION WITH NFATC2IP. |
| [7] | "Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT." Aramburu J., Garcia-Cozar F., Raghavan A., Okamura H., Rao A., Hogan P.G. Mol. Cell 1:627-637(1998) [PubMed: 9660947] [Abstract] Cited for: MUTAGENESIS OF ARG-112; GLU-114 AND THR-116. |
| [8] | "Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT." Crabtree G.R. Cell 96:611-614(1999) [PubMed: 10089876] [Abstract] Cited for: REVIEW. |
| [9] | "Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity." Okamura H., Aramburu J., Garcia-Rodriguez C., Viola J.P.B., Raghavan A., Tahiliani M., Zhang X., Qin J., Hogan P.G., Rao A. Mol. Cell 6:539-550(2000) [PubMed: 11030334] [Abstract] Cited for: PHOSPHORYLATION AT SER-99; SER-136; SER-170; SER-173; SER-174; SER-176; SER-177; SER-179; SER-182; SER-215; SER-219; SER-223; SER-238; SER-245; SER-270; SER-276; SER-278; SER-282; SER-328 AND SER-365, SUBCELLULAR LOCATION, INTERACTION WITH XPO1, MUTAGENESIS OF ARG-164, MASS SPECTROMETRY. |
| [10] | "Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry." Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J., Faessler R., Mann M. J. Proteome Res. 7:5314-5326(2008) [PubMed: 18973353] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-270, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U02079 mRNA. Translation: AAC52929.1. Sequence problems. U36575 mRNA. Translation: AAC52930.1. U36576 mRNA. Translation: AAC52931.1. AF289078 mRNA. Translation: AAK49895.1. AL840639, AL844575 Genomic DNA. Translation: CAM15662.1. AL840639, AL844575 Genomic DNA. Translation: CAM15663.1. AL844575 Genomic DNA. Translation: CAM15669.1. AL844575, AL840639 Genomic DNA. Translation: CAM15670.1. AL844575, AL840639 Genomic DNA. Translation: CAM15671.1. |
| IPI | IPI00229456. IPI00314662. IPI00911162. |
| PIR | A48753. |
| RefSeq | NP_001032254.1. NP_001129545.1. NP_035029.2. |
| UniGene | Mm.116802 |
3D structure databases | |
| SMR | Q60591. Positions 394-680. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q60591. 8 interactions. |
| STRING | Q60591. |
PTM databases | |
| PhosphoSite | Q60591. |
Proteomic databases | |
| PRIDE | Q60591. |
Genome annotation databases | |
| Ensembl | ENSMUST00000029057; ENSMUSP00000029057; ENSMUSG00000027544; Mus musculus. [Genome view] ENSMUST00000074618; ENSMUSP00000074198; ENSMUSG00000027544; Mus musculus. [Genome view] ENSMUST00000099068; ENSMUSP00000096667; ENSMUSG00000027544; Mus musculus. [Genome view] ENSMUST00000109186; ENSMUSP00000104813; ENSMUSG00000027544; Mus musculus. [Genome view] |
| GeneID | 18019. |
| KEGG | mmu:18019. |
| UCSC | uc008oau.1. mouse. uc008oav.1. mouse. |
Organism-specific databases | |
| CTD | 18019. |
| MGI | MGI:102463. Nfatc2. |
Phylogenomic databases | |
| eggNOG | roNOG07381. |
| HOVERGEN | Q60591. |
| InParanoid | Q60591. |
Gene expression databases | |
| ArrayExpress | Q60591. |
| Bgee | Q60591. |
| Genevestigator | Q60591. |
| GermOnline | ENSMUSG00000027544. Mus musculus. |
Family and domain databases | |
| InterPro | IPR013783. Ig-like_fold. IPR014756. Ig_E-set. IPR002909. IPT_TIG_rcpt. IPR008366. NFAT. IPR018286. NFAT_sbgrp. IPR008967. p53-like_TF_DNA-bd. IPR011539. RHD. [Graphical view] |
| Gene3D | G3DSA:2.60.40.10. Ig-like_fold. 1 hit. G3DSA:2.60.40.340. RHD. 1 hit. |
| PANTHER | PTHR12533. NFAT. 1 hit. |
| Pfam | PF00554. RHD. 1 hit. PF01833. TIG. 1 hit. [Graphical view] |
| PRINTS | PR01789. NUCFACTORATC. |
| SMART | SM00429. IPT. 1 hit. [Graphical view] |
| PROSITE | PS01204. REL_1. False negative. PS50254. REL_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 293063. |
| SOURCE | Search... |
Entry information
| Entry name | NFAC2_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q60591 Secondary accession number(s): A2APK2 Q91Y65 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


